3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.21%
Positive revenue growth while MZX.DE is negative. John Neff might see a notable competitive edge here.
-55.14%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
17.70%
Positive EBIT growth while MZX.DE is negative. John Neff might see a substantial edge in operational management.
56.40%
Positive operating income growth while MZX.DE is negative. John Neff might view this as a competitive edge in operations.
19.91%
Positive net income growth while MZX.DE is negative. John Neff might see a big relative performance advantage.
18.42%
Positive EPS growth while MZX.DE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
18.42%
Positive diluted EPS growth while MZX.DE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.20%
Share count expansion well above MZX.DE's 2.28%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.20%
Diluted share count expanding well above MZX.DE's 2.28%. Michael Burry would fear significant dilution to existing owners' stakes.
18.14%
Dividend growth of 18.14% while MZX.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-57.95%
Negative OCF growth while MZX.DE is at 756.34%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-69.63%
Negative FCF growth while MZX.DE is at 101.40%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
65.64%
Positive 10Y revenue/share CAGR while MZX.DE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.73%
3Y revenue/share CAGR under 50% of MZX.DE's 37.52%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.43%
Net income/share CAGR at 50-75% of MZX.DE's 122.60%. Martin Whitman might question if the firm’s product or cost base lags behind.
No Data
No Data available this quarter, please select a different quarter.
-18.30%
Negative 3Y CAGR while MZX.DE is 200.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
128.08%
Equity/share CAGR of 128.08% while MZX.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
No Data
No Data available this quarter, please select a different quarter.
93.54%
3Y equity/share CAGR 1.25-1.5x MZX.DE's 72.50%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.14%
AR growth well above MZX.DE's 3.51%. Michael Burry fears inflated revenue or higher default risk in the near future.
25.89%
Inventory growth well above MZX.DE's 3.45%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.70%
Positive asset growth while MZX.DE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.10%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
91.53%
Debt growth far above MZX.DE's 3.31%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-51.43%
We cut SG&A while MZX.DE invests at 0.90%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.